COMPANION DIAGNOSTICS AGREEMENTCompanion Diagnostics Agreement • August 11th, 2020 • Aprea Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 11th, 2020 Company IndustryThis Companion Diagnostics Agreement (this “Agreement”) dated August 11, 2020 (the “Effective Date”), by and between Invivoscribe, Inc., a California corporation with offices located at 10222 Barnes Canyon Rd., Building 1, San Diego, CA 92121 (“IVS”), and Aprea Therapeutics, Inc., a Delaware corporation (“APR”) with offices located at 535 Boylston Street, Boston, MA 02116 (each a “Party” and collectively the “Parties”).